CLDX
Celldex Therapeutics Inc
31.50$
+1.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +17.9% | +2.0% | +29.8% | -28.4% | +27.8% | -19.1% | -21.9% | -54.4% | +114.9% | +5.6% | -177.9% | |
| – | +86.4% | +19.9% | -19.6% | -34.4% | -43.7% | -14.0% | +128.7% | +74.4% | +53.0% | +43.3% | +5.8% | |
| – | +86.6% | +20.5% | -98.1% | +30,976.5% | -94.3% | +210.7% | -51.8% | +26.4% | – | – | – | |
| – | +77.7% | -160.3% | – | – | – | – | – | – | – | -260.5% | – | |
| – | +152.8% | -43.6% | -35.0% | -54.5% | -10.1% | +112.3% | -19.5% | +46.4% | -0.5% | +5.6% | +41.4% | |
| – | +22.4% | – | -32.6% | -35.8% | -42.7% | -675.0% | +120.1% | – | -217.6% | +174.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +16,394.5% | -92.5% | +254.2% | -42.6% | -44.8% | +953.2% | +59.1% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +16,394.5% | -92.5% | +254.2% | -42.6% | -44.8% | +953.2% | +59.1% | -98.5% | +5,259.6% | +102.1% | -99.5% | |
| – | – | -167.2% | – | – | – | – | -114.4% | – | – | -219.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.